Bionano Genomics, Inc. (BMV:BNGO)
Mexico · Delayed Price · Currency is MXN 19.99
-3.01 (-13.09%)
Last updated: Feb 9, 2026, 1:58 PM CST
Bionano Genomics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -38.59 | -112.02 | -232.49 | -132.6 | -72.44 | -41.11 |
Depreciation & Amortization | 9.79 | 14.23 | 13.91 | 9.84 | 3.37 | 1.48 |
Loss (Gain) From Sale of Assets | 0.26 | 1.4 | - | - | - | - |
Asset Writedown & Restructuring Costs | 1.02 | 19.68 | 77.28 | - | - | - |
Loss (Gain) From Sale of Investments | -0 | 0.01 | 0.02 | 0.07 | - | - |
Stock-Based Compensation | 5.54 | 9.74 | 15.18 | 22.42 | 9.72 | 1.55 |
Provision & Write-off of Bad Debts | - | - | - | - | - | 1.81 |
Other Operating Activities | 0.78 | -6.37 | 15.69 | 3.4 | -4.93 | 1.39 |
Change in Accounts Receivable | 0.36 | 4.14 | -2.3 | -2.25 | -0.49 | 2.09 |
Change in Inventory | 6.28 | -0.59 | -4.15 | -23.68 | -15.93 | -4.2 |
Change in Accounts Payable | -2.71 | -3.42 | -2 | 1.95 | 6.78 | -1.81 |
Change in Other Net Operating Assets | -1.4 | 4.27 | -6.33 | -3.96 | 1.99 | 0.48 |
Operating Cash Flow | -18.67 | -68.92 | -125.18 | -124.82 | -71.93 | -38.31 |
Capital Expenditures | - | -0.1 | -1.69 | -3.2 | -1.46 | - |
Sale of Property, Plant & Equipment | - | - | - | 0.03 | - | - |
Cash Acquisitions | - | - | 0.1 | -30.65 | -49.09 | -2.45 |
Sale (Purchase) of Intangibles | - | - | - | -0.1 | - | - |
Investment in Securities | -13.76 | 73.94 | 25.75 | 116.69 | -226.91 | - |
Other Investing Activities | - | - | - | - | -0.61 | - |
Investing Cash Flow | -13.76 | 73.84 | 24.16 | 82.77 | -278.06 | -2.45 |
Short-Term Debt Issued | - | 18 | 80 | - | - | - |
Long-Term Debt Issued | - | - | - | - | - | 2.54 |
Total Debt Issued | - | 18 | 80 | - | - | 2.54 |
Short-Term Debt Repaid | - | -66 | -9 | - | - | - |
Long-Term Debt Repaid | - | -0.06 | -0.05 | -0.04 | -15.01 | -7.26 |
Total Debt Repaid | -6.94 | -66.06 | -9.05 | -0.04 | -15.01 | -7.26 |
Net Debt Issued (Repaid) | -6.94 | -48.06 | 70.95 | -0.04 | -15.01 | -4.72 |
Issuance of Common Stock | 36.08 | 44.45 | 57.83 | 23.62 | 352.82 | 68.63 |
Repurchase of Common Stock | - | - | - | - | - | -2 |
Other Financing Activities | -2.81 | -10.08 | -14.97 | -0.58 | -1.7 | - |
Financing Cash Flow | 26.33 | -13.69 | 113.82 | 23.01 | 336.11 | 61.9 |
Foreign Exchange Rate Adjustments | -0.02 | -0.01 | 0.07 | -0.04 | - | - |
Net Cash Flow | -6.13 | -8.78 | 12.86 | -19.08 | -13.88 | 21.14 |
Free Cash Flow | -18.67 | -69.03 | -126.87 | -128.02 | -73.39 | -38.31 |
Free Cash Flow Margin | -65.02% | -224.28% | -351.29% | -460.46% | -408.14% | -450.59% |
Free Cash Flow Per Share | -5.69 | -54.31 | -222.97 | -265.58 | -159.09 | -220.51 |
Cash Interest Paid | 1.83 | 10.65 | 1.65 | 0.3 | 1.91 | 1.25 |
Levered Free Cash Flow | 2.82 | 4.19 | -97.26 | -61.27 | -38.49 | -16.43 |
Unlevered Free Cash Flow | 3.17 | 5.46 | -94.06 | -61.08 | -37.91 | -14.85 |
Change in Working Capital | 2.52 | 4.4 | -14.77 | -27.94 | -7.65 | -3.44 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.